Financhill
Back

Summit Therapeutics Quote, Financials, Valuation and Earnings

Summit Therapeutics Price Quote

$19.49
-1.27 (-6.12%)
(Updated: November 13, 2024 at 5:55 PM ET)

Summit Therapeutics Key Stats

Buy
68
Summit Therapeutics (SMMT) is a Buy

Day range:
$20.74 - $22.25
52-week range:
$1.82 - $33.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15,406.21
P/B ratio:
34.96%

Volume:
1.9M
Avg. volume:
2.7M
1-year change:
989.76%
Market cap:
$15.3B
Revenue:
$0
EPS:
$-0.24

How Much Does Summit Therapeutics Make?

Data Unavailable

Is Summit Therapeutics Growing As A Company?

Data Unavailable

Summit Therapeutics Stock Price Performance

What Is Summit Therapeutics 52-Week High & Low?

Summit Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Summit Therapeutics?

Is Summit Therapeutics Cash Flow Positive?

  • What Is SMMT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$112.9M
  • What Is Summit Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $411.1M
  • What Is Summit Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$228.3M

Summit Therapeutics Return On Invested Capital

Data Unavailable

Summit Therapeutics Earnings Date & Stock Price

Summit Therapeutics Competitors

Summit Therapeutics Dividend Yield

Summit Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -19.41%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 34.70
Upside from Last Price: 67.15%

Major Shareholders

  • How many SMMT shares are owned by institutional investors?
    102.3M SMMT shares are owned by institutional investors
  • How many SMMT shares are owned by insiders?
    142.7M SMMT shares are owned by insiders